F
F

FreseniusMedical

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Rheinmetall bumped up to Germany's DAX index on increased defence spending

UPDATE 1-Rheinmetall bumped up to Germany's DAX index on increased defence spending Add details on index entrant By Miranda Murray and Ludwig Burger BERLIN, March 3 (Reuters) - Defence contractor Rheinmetall RHMG.DE will join Germany's DAX .GDAXI index this month, Deutsche Boerse DB1Gn.DE said on Friday, with increased defence spending due to the war in Ukraine bumping it up into the club of blue-chip companies.
C
D
P
R
S
V
A
F
U
U
G

Fresenius takes tentative step on road to breakup

BREAKINGVIEWS-Fresenius takes tentative step on road to breakup The author is a Reuters Breakingviews columnist. The opinions expressed are their own. LONDON, Feb 22 (Reuters Breakingviews) - Fresenius’s FREG.DE sprawling business is getting tighter. On Tuesday evening the $17 billion German medical technology company said it will relinquish control of its listed dialysis firm, Fresenius Medical Care FMEG.DE , in order to focus on its core businesses.
C
F
S
F

U.S. STOCKS Baidu, Alcoa, Palo Alto Networks

BUZZ-U.S. STOCKS ON THE MOVE-Baidu, Alcoa, Palo Alto Networks Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures were trading flat on Wednesday after Wall Street posted its worst performance of the year a day earlier as investors traded cautiously ahead of the minutes from the Federal Reserve's latest rate-setting meeting.
A
B
C
N
F
R
U

V-shaped recovery in European equities "implausible" for now - UBS

LIVE MARKETS-V-shaped recovery in European equities "implausible" for now - UBS STOXX 600 down 0.8% Financials top drag Fed minutes eyed U.S. futures tick lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com V-SHAPED RECOVER IN EUROPEAN EQUITIES "IMPLAUSIBLE" FOR NOW - UBS (1134 GMT) European equities need to pause for more data to validate the V-shaped recovery currently being
E
G
L
N
N
T
F
I
R
S
E
F
U
G

Only half the STOXX yields more than bonds

LIVE MARKETS-Only half the STOXX yields more than bonds STOXX 600 down 0.8% Financials top drag Fed minutes eyed U.S. futures tick lower Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com ONLY HALF THE STOXX YIELDS MORE THAN BONDS (1125 GMT) The relentless surge in bond yields has made pursuing equity income strategies somewhat more complicated.
E
G
L
N
N
T
F
I
R
S
E
F
U
G

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.